New York Post
•Health
Health
Biden’s parting gift to Big Pharma will hammer GLP-1 patients — like me
Summary
Nutrition label
61% Informative
In the final weeks of his administration, President Biden ’s Food and Drug Administration quietly ended the “shortage” of tirzepatide, a popular GLP-1 medication.
That means on March 19 , safe, lower-cost alternatives will be removed from the market.
Dr. Marty Makary , President Trump 's nominee as FDA commissioner, is on Capitol Hill on Thursday .
VR Score
54
Informative language
46
Neutral language
31
Article tone
semi-formal
Language
English
Language complexity
58
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links